3,065
Views
3
CrossRef citations to date
0
Altmetric
Pain Management

The effect of pregabalin treatment on balance and gait in patients with chronic low back pain: a retrospective observational study

ORCID Icon, , , &
Pages 32-35 | Received 07 Aug 2018, Accepted 06 Dec 2018, Published online: 27 Feb 2019

References

  • Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2163–2196.
  • Dagenais S, Caro J, Haldeman S. A systematic review of low back pain cost of illness studies in the United States and internationally. The Spine Journal: official Journal of the North American Spine Society. 2008;8:8–20.
  • Frymoyer JW, Cats-Baril WL. An overview of the incidences and costs of low back pain. Orthop Clin North Am. 1991;22:263–271.
  • Von Korff M, Saunders K. The course of back pain in primary care. Spine. 1996;21:2833–2839.
  • Woolf CJ, Bennett GJ, Doherty M, et al. Towards a mechanism-based classification of pain? Pain. 1998;77:227–229.
  • Baron R, Binder A. [How neuropathic is sciatica? The mixed pain concept]. Orthopade. 2004;33:568–575.
  • Freynhagen R, Rolke R, Baron R, et al. Pseudoradicular and radicular low-back pain–a disease continuum rather than different entities? Answers from quantitative sensory testing. Pain. 2008;135:65–74.
  • Qaseem A, Wilt TJ, McLean RM, et al. Noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the american college of physicians. Ann Intern Med. 2017;166:514–530.
  • Chou R, Huffman LH, American Pain S, et al. Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline. Ann Intern Med. 2007;147:505–514.
  • Vranken JH, Dijkgraaf MG, Kruis MR, et al. Pregabalin in patients with central neuropathic pain: a randomized, double-blind, placebo-controlled trial of a flexible-dose regimen. Pain. 2008;136:150–157.
  • Semel D, Murphy TK, Zlateva G, et al. Evaluation of the safety and efficacy of pregabalin in older patients with neuropathic pain: results from a pooled analysis of 11 clinical studies. BMC Family Practice. 2010;11:85.
  • Bouhassira D, Attal N, Alchaar H, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005;114:29–36.
  • Unal-Cevik I, Sarioglu-Ay S, Evcik D. A comparison of the DN4 and LANSS questionnaires in the assessment of neuropathic pain: validity and reliability of the Turkish version of DN4. The Journal of Pain: Official Journal of the American Pain Society. 2010;11:1129–1135.
  • Rubenstein L. Instrumentos de evaluación. El manual Merck de geriatría (ed Esp) Barcelona (Spain): Doyma; 1992. p. 1251–63.
  • Gajraj NM. Pregabalin: its pharmacology and use in pain management. Anesth Analg. 2007;105:1805–1815.
  • Bockbrader HN, Radulovic LL, Posvar EL, et al. Clinical pharmacokinetics of pregabalin in healthy volunteers. J Clin Pharmacol. 2010;50:941–950.
  • Freynhagen R, Grond S, Schupfer G, et al. Efficacy and safety of pregabalin in treatment refractory patients with various neuropathic pain entities in clinical routine. Int J Clin Pract. 2007;61:1989–1996.
  • Freynhagen R, Serpell M, Emir B, et al. A comprehensive drug safety evaluation of pregabalin in peripheral neuropathic pain. Pain Pract. 2015;15:47–57.
  • Şavk E. Neurologic itch management. Itch-management in clinical practice. Curr Probl Dermatol. Basel, Karger, 2016, vol 50, pp 116–123.
  • Griffin E, Brown JN. Pregabalin for the treatment of restless legs syndrome. Ann Pharmacother. 2016;50:586–591.
  • Li F, Ma J, Kuang M, et al. The efficacy of pregabalin for the management of postoperative pain in primary total knee and hip arthroplasty: a meta-analysis. J Orthop Surg Res. 2017;12:49
  • Corna S, Aspesi V, Cau N, et al. Dizziness and falls in obese inpatients undergoing metabolic rehabilitation. PloS One. 2017;12:e0169322.
  • Skøien AK, Wilhemsen K, Gjesdal S. Occupational disability caused by dizziness and vertigo: a register-based prospective study. Br J Gen Pract. 2008;58:619–623.
  • Kannus P, Parkkari J, Koskinen S, et al. Fall-induced injuries and deaths among older adults. Jama. 1999;281:1895–1899.
  • Tinetti ME, Speechley M, Ginter SF. Risk factors for falls among elderly persons living in the community. N Engl J Med. 1988;319:1701–1707.
  • Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: II. Cardiac and analgesic drugs. J Am Geriatr Soc. 1999;47:40–50.
  • Woolcott JC, Richardson KJ, Wiens MO, et al. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med. 2009;169:1952–1960.
  • Hartholt KA, Becker ML, van der Cammen TJ. Drug-induced falls in older persons: is there a role for therapeutic drug monitoring? Ther Adv Drug Saf. 2016;7:39–42.
  • Romanò CL, Romanò D, Bonora C, et al. Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain. J Orthop Traumatol. 2009;10:185–191.
  • Tzellos TG, Papazisis G, Amaniti E, et al. Efficacy of pregabalin and gabapentin for neuropathic pain in spinal-cord injury: an evidence-based evaluation of the literature. Eur J Clin Pharmacol. 2008;64:851–858.